Skip to main content
. 2020 Sep 25;10:15760. doi: 10.1038/s41598-020-72045-z

Table 2.

Best performing medication scores evaluated in three separate validation datasets by C-index and Negelkerke R2.

Score derivation method Number of medications included Main cohort
FINRISK validation subset
Replication cohorts
R2 C-index
∆C baseline
R2 C-index (95% CI)
∆C baseline (95% CI)
H2000 Estonia H2000 Estonia
Baseline model (age and sex) 0.134 0.766 (0.745–0.788) 0.309 0.098 0.823 0.775
Expert consensus panel 166 0.149 0.779 (0.758–0.800) 0.316 0.107 0.827 0.786
 + 0.013 (0.006–0.019)  + 0.004  + 0.011
Number of medications 301 0.148 0.777 (0.756–0.798) 0.317 0.104 0.828 0.785
 + 0.011 (0.005–0.017)  + 0.005  + 0.010
Shotgun stochastic search 8 0.158 0.785 (0.764–0.806) 0.317 0.102 0.827 0.781
 + 0.019 (0.01–0.027)  + 0.004  + 0.006
Cox LASSO 65 0.164 0.791 (0.771–0.812) 0.324 0.109 0.830 0.793
 + 0.025 (0.017–0.033)  + 0.007  + 0.018
Cox LASSO signs only 65 0.162 0.791 (0.770–0.811) 0.320 0.110 0.829 0.791
 + 0.025 (0.017–0.032)  + 0.006  + 0.016
Ridge regression 301 0.164 0.793 (0.772–0.813) 0.322 0.113 0.830 0.795
 + 0.026 (0.018–0.034)  + 0.007  + 0.020
Elastic net 214 0.166 0.794 (0.773–0.814) 0.324 0.108 0.830 0.784
 + 0.028 (0.019–0.036)  + 0.007  + 0.009

H2000 does not include all the ATC codes of the derivation set.